Cerebral perfusion imaging using contrast-enhanced MRI

Clinical Radiology

Volumn 58, Issue 7, 2003, Pages 505-513

  Keston, Peter ^a   Murray, A D ^a   Jackson, A ^b  

^a Academic Department of Radiology   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Brain; Contrast media; Haemodynamics; Magnetic resonance imaging

Indexed keywords

GADOLINIUM;

BRAIN ANGIOGRAPHY; BRAIN BLOOD FLOW; BRAIN PERFUSION; BRAIN TUMOR; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; HEMODYNAMICS; HUMAN; INTERMETHOD COMPARISON; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW; STROKE; TECHNIQUE;

EID: 0038083129     PISSN: 00099260     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9260(03)00130-2     Document Type: Review

References (85)

1. Barbier EL, Lamalle L, Decorps M. Methodology of brain perfusion imaging. J Magn Reson Imaging, 2001;13:496-520.
2. Calamante F, Thomas DL, Pell GS, et al. Measuring cerebral blood flow using magnetic resonance imaging techniques. J Cereb Blood Flow Metab, 1999;19:701-735.
3. Rosen BR, Belliveau JW, Aronen HJ, et al. Susceptibility contrast imaging of cerebral blood volume: human experience. Magn Reson Med, 1991;22:293-299.
4. Boxerman JL, Rosen BR, Weisskoff RM. Signal-to-noise analysis of cerebral blood volume maps from dynamic NMR imaging studies. J Magn Reson Imaging, 1997;7:528-537.
5. Jezzard P. Advances in perfusion MR imaging. Radiology, 1998;208: 296-299.
6. Koshimoto Y, Yamada H, Kimura H, et al. Quantitative analysis of cerebral microvascular hemodynamics with T2-weighted dynamic MR imaging. J Magn Reson Imaging, 1999;9:462-467.
7. Sorensen AG, Reimer P. Cerebral MR Perfusion Imaging, 1st edn New York: Thieme, 2000.
8. Kiselev VG. On the theoretical basis of perfusion measurements by dynamic susceptibility contrast MRI. Magn Reson Med, 2001;46: 1113-1122.
9. Unger EC, Ugurbil K, Latchaw RE. Contrast agents for cerebral perfusion MR imaging. J Magn Reson Imaging, 1994;4:235-242.
10. Wang YX, Hussain SM, Krestin GP. Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging. Eur Radiol, 2001;11:2319-2331.
11. Belliveau, J. W., McKinstry, R., Kennedy, D. N., et al. Functional imaging by gamma analysis of contrast enhanced NMR. 8th Annual Meeting of the Society of Magnetic Resonance in Medicine, 1989; 63.
12. Benner T, Heiland S, Erb G, et al. Accuracy of gamma-variate fits to concentration-time curves from dynamic susceptibility-contrast enhanced MRI: influence of time resolution, maximal signal drop and signal to noise. Magn Reson Imaging, 1997;15:307-317.
13. Rosen BR, Belliveau JW, Vevea JM, Brady TJ. Perfusion imaging with NMR contrast agents. Magn Reson Med, 1990;14:249-265.
14. Aronen HJ, Gazit IE, Louis DN, et al. Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology, 1994;191:41-51.
15. Kuhl CK, Bieling H, Gieseke J, et al. Breast neoplasms: T2* susceptibility-contrast, first-pass perfusion MR imaging. Radiology, 1997;202:87-95.
16. Maeda M, Maley JE, Crosby DL. Application of contrast agents in the evaluation of stroke: conventional MR and echo-planar MR imaging. J Magn Reson Med, 1997;7:723-728.
17. Miyati T, Banno T, Mase M, et al. Dual dynamic contrast-enhanced MR imaging. J Magn Reson Imaging, 1997;7:230-235.
18. Bullock PR, Mansfield P, Gowland P, et al. Dynamic imaging of contrast enhancement in brain tumors. Magn Reson Med, 1991;19: 293-298.
19. Gowland P, Mansfield P, Bullock P, et al. Dynamic studies of gadolinium uptake in brain tumors using inversion-recovery echoplanar imaging. Magn Reson Med, 1992;26:241-258.
20. Calamante F, Gadian DG, Connelly A. Delay and dispersion effects in dynamic susceptibility contrast MRI: simulations using singular value decomposition. Magn Reson Med, 2000;44:466-473.
21. Rempp KA, Brix G, Wenz F, et al. Quantification of regional cerebral blood flow and volume with dynamic susceptibility contrast-enhanced MR imaging. Radiology, 1994;193:637-641.
22. Weisskoff RM, Chesler D, Boxerman JL, Rosen BR. Pitfalls in MR measurement of tissue blood flow with intravascular tracers: which mean transit time? Magn Reson Med, 1993;29:553-558.
23. Ostergaard L, Hochberg FH, Rabinov JD, et al. Early changes measured by magnetic resonance imaging in cerebral blood flow, blood volume, and blood-brain barrier permeability following dexamethasone treatment in patients with brain tumors. J Neurosurg, 1999;90:300-305.
24. Ostergard L, Sorensen AG, Kwong KK. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part II: Experimental comparison and preliminary results. Magn Reson Med, 1996;36:726-736.
25. 2O positron emission tomography in humans. J Cereb Blood Flow Metab, 1998;18:935-940.
26. Lythgoe DJ, Ostergaard L, William SC, et al. Quantitative perfusion imaging in carotid artery stenosis using dynamic susceptibility contrast-enhanced magnetic resonance imaging. Magn Reson Imaging, 2000;18: 1-11.
27. Thacker N, Zhu X, Jackson A, Lacey A. A new approach for the estimation of MTT in bolus passage perfusion techniques. Proceedings of the 8th Annual Meeting of the ISMRM, Denver, CO, USA, 2000; 524.
28. Calamante F, Ganesan V, Kirkham FJ, et al. MR perfusion imaging in moyamoya syndrome: potential implications for clinical evaluation of occlusive cerebrovascular disease. Stroke, 2001;32:2810-2816.
29. Calamante F, Gadian DG, Connelly A. Quantification of perfusion using bolus tracking magnetic resonance imaging in stroke: assumptions, limitations, and potential implications for clinical use. Stroke, 2002;33:1146-1151.
30. Karonen JO, Ostergaard L, Vainio P, et al. Diffusion and perfusion MR imaging in acute ischemic stroke: a comparison to SPECT. Comput Methods Prog Biomed, 2001;66:125-128.
31. Kucharczyk J, Mintorovitch J, Asgari HS, Moseley M. Diffusion/perfusion MR imaging of acute cerebral ischemia. Magn Reson Med, 1991;19:311-335.
32. Keir SL, Wardlaw JM. Systematic review of diffusion and perfusion imaging in acute ischemic stroke. Stroke, 2000;31:2723-2731.
33. Hoggard N, Wilkinson ID, Griffiths PD. The imaging of ischaemic stroke. Clin Radiol, 2001;56:171-183.
34. Latchaw RE. The roles of diffusion and perfusion MR imaging in acute stroke management. AJNR Am J Neuroradiol, 1999;20:957-959.
35. Lees KR. ECASS-II: intravenous alteplase in acute ischaemic stroke. European Co-Operative Acute Stroke Study-II. Lancet, 1999;353: 65-66.
36. Rohl L, Sakoh M, Simonsen CZ. Time evolution of cerebral perfusion and apparent diffusion coefficient measured by magnetic resonance imaging in a porcine stroke model. J Magn Reson Imaging, 2002;15: 123-129.
37. Sunshine JL, Bambakidis N, Tarr RW, et al. Benefits of perfusion MR imaging relative to diffusion MR imaging in the diagnosis and treatment of hyperacute stroke. AJNR Am J Neuroradiol, 2001;22:915-921.
38. Schellinger PD, Jansen O, Fiebach JB, et al. Feasibility and practicality of MR imaging of stroke in the management of hyperacute cerebral ischemia. AJNR Am J Neuroradiol, 2000;21:1184-1189.
39. Wittsack HJ, Ritzl A, Fink GR. MR imaging in acute stroke: diffusion-weighted and perfusion imaging parameters for predicting infarct size. Radiology, 2002;222:397-403.
40. Parsons MW, Yang Q, Barber PA, et al. Perfusion magnetic resonance imaging maps in hyperacute stroke: relative cerebral blood flow most accurately identifies tissue destined to infarct. Stroke, 2001;32: 1581-1587.
41. Grandin CB, Duprez TP, Smith AM, et al. Which MR-derived perfusion parameters are the best predictors of infarct growth in hyperacute stroke? Comparative study between relative and quantitative measurements. Radiology, 2002;223:361-370.
42. Ostergaard L, Sorensen AG, Chesler DA, et al. Combined diffusion-weighted and perfusion-weighted flow heterogeneity magnetic resonance imaging in acute stroke. Stroke, 2000;31:1097-1103.
43. Uno M, Harada M, Yoneda K, et al. Can diffusion- and perfusion-weighted magnetic resonance imaging evaluate the efficacy of acute thrombolysis in patients with internal carotid artery or middle cerebral artery occlusion? Neurosurgery, 2002;50:28-34.
44. Parsons MW, Barber PA, Chalk J, et al. Diffusion- and perfusion-weighted MRI response to thrombolysis in stroke. Ann Neurol, 2002;51: 28-37.
45. Kidwell CS, Saver JL, Mattiello J, et al. Diffusion-perfusion MRI characterization of post-recanalization hyperperfusion in humans. Neurology, 2001;57:2015-2021.
46. Marks MP, Tong DC, Beaulieu C, et al. Evaluation of early reperfusion and i.v. TPA therapy using diffusion- and perfusion-weighted MRI. Neurology, 1999;52:1792-1798.
47. Schellinger PD, Jansen O, Fiebach JB, et al. Monitoring intravenous recombinant tissue plasminogen activator thrombolysis for acute ischemic stroke with diffusion and perfusion MRI. Stroke, 2000;31: 1318-1328.
48. Marstrand JR, Garde E, Rostrup E, et al. Cerebral perfusion and cerebrovascular reactivity are reduced in white matter hyperintensities. Stroke, 2002;33:972-976.
49. O'Sullivan M, Lythgoe DJ, Pereira AC, et al. Patterns of cerebral blood flow reduction in patients with ischemic leukoaraiosis. Neurology, 2002;59:321-326.
50. Cha S, Knopp EA, Johnson G, et al. Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging. Radiology, 2002;223:11-29.
51. Knopp MV, Essig M, Hawighorst H, et al. Functional neuroimaging in the assessment of CNS neoplasms. Eur Radiol, 1997;7(Suppl. 5): 209-215.
52. Sugahara. T, Korogi Y, Kochi M, et al. Perfusion-sensitive MR imaging of gliomas: comparison between gradient-echo and spin-echo echo-planar imaging techniques. AJNR Am J Neuroradiol, 2001;22: 1306-1315.
53. Uematsu H, Maeda M, Sadato N, et al. Blood volume of gliomas determined by double-echo dynamic perfusion-weighted MR imaging: a preliminary study. AJNR Am J Neuroradiol, 2001;22:1915-1919.
54. Jackson A, Kassner A, Zhu XP, Li KL. Reproducibility of T2* blood volume and vascular tortuosity maps in cerebral gliomas. J Magn Reson Imaging, 2001;14:510-516.
55. Jackson A, Kassner A, Annesley-Williams D, et al. Abnormalities in the recirculation phase of contrast agent bolus passage in cerebral gliomas: comparison with relative blood volume and tumor grade. AJNR Am J Neuroradiol, 2002;23:7-14.
56. Chan JH, Tsui EY, Chau LF, et al. Discrimination of an infected brain tumor from a cerebral abscess by combined MR perfusion and diffusion imaging. Comput Med Imaging Graphics, 2002;26:19-23.
57. Law M, Cha S, Knopp EA, et al. High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging. Radiology, 2002;222:715-721.
58. Cha S, Pierce S, Knopp EA, et al. Dynamic contrast-enhanced T2*-weighted MR imaging of tumefactive demyelinating lesions. AJNR Am J Neuroradiol, 2001;22:1109-1116.
59. Ernst TM, Chang L, Witt MD, et al. Cerebral toxoplasmosis and lymphoma in AIDS: perfusion MR imaging experience in 13 patients. Radiology, 1998;208:663-669.
60. Lee SJ, Kim JH, Kim YM, et al. Perfusion MR imaging in gliomas: comparison with histologic tumor grade. Korean J Radiol, 2001;2:1-7.
61. Ludemann L, Grieger W, Wurm R, et al. Comparison of dynamic contrast-enhanced MRI with WHO tumor grading for gliomas. Eur Radiol, 2001;11:1231-1241.
62. Provenzale JM, Wang GR, Brenner T, et al. Comparison of permeability in high-grade and low-grade brain tumors using dynamic susceptibility contrast MR imaging. AJR Am J Roentgenol, 2002;178: 711-716.
63. Yang D, Korogi Y, Sugahara T, et al. Cerebral gliomas: prospective comparison of Multivoxel 2D chemical-shift imaging proton MR spectroscopy, echoplanar perfusion and diffusion-weighted MRI. Neuroradiology, 2002;44:656-666.
64. Gossmann A, Helbich TH, Kuriyama N, et al. Dynamic contrast-enhanced magnetic resonance imaging as a surrogate marker of tumor response to anti-angiogenic therapy in a xenograft model of glioblastoma multiforme. J Magn Reson Imaging, 2002;15:233-240.
65. Roberts HC, Roberts TP, Brasch RC, Dillon WP. Quantitative measurement of microvascular permeability in human brain tumors achieved using dynamic contrast-enhanced MR imaging: correlation with histologic grade. AJNR Am J Neuroradiol, 2000;21:891-899.
66. Uematsu H, Maeda M, Sadato N, et al. Vascular permeability: quantitative measurement with double-echo dynamic MR imaging-theory and clinical application. Radiology, 2000;214:912-917.
67. Zhu XP, Li KL, Kamaly-Asl ID, et al. Quantification of endothelial permeability, leakage space, and blood volume in brain tumors using combined T1 and T2* contrast-enhanced dynamic MR imaging. J Magn Reson Imaging, 2000;11:575-585.
68. Wenz F, Rempp K, Hess T, et al. Effect of radiation on blood volume in low-grade astrocytomas and normal brain tissue: quantification with dynamic susceptibility contrast MR imaging. AJR Am J Roentgenol, 1996;166:187-193.
69. Bozzao A, Floris R, Baviera ME, et al. Diffusion and perfusion MR imaging in cases of Alzheimer's disease: correlations with cortical atrophy and lesion load. AJNR Am J Neuroradiol, 2001;22:1030-1036.
70. Harris GJ, Lewis RF, Satlin A, et al. Dynamic susceptibility contrast MR imaging of regional cerebral blood volume in Alzheimer's disease: a promising alternative to nuclear medicine. AJNR Am J Neuroradiol, 1998;19:1727-1732.
71. Li KL, Suojanen JN. Cocaine-induced changes in time course of regional cerebral blood volume and transit time as determined by dynamic MR imaging. J Magn Reson Imaging, 1995;5:715-718.
72. Lorenz IH, Kolbitsch C, Hormann C, et al. Influence of equianaesthetic concentrations of nitrous oxide and isoflurane on regional cerebral blood flow, regional cerebral blood volume, and regional mean transit time in human volunteers. BJA: Br J Anaesth, 2001;87:691-698.
73. Reneman L, Habraken JB, Majoie CB, et al. MDMA ("Ecstasy") and its association with cerebrovascular accidents: preliminary findings. AJNR Am J Neuroradiol, 2000;21:1001-1007.
74. Reneman L, Majoie CB, Habraken JB, den Heeten GJ. Effects of ecstasy (MDMA) on the brain in abstinent users: initial observations with diffusion and perfusion MR imaging. Radiology, 2001;220: 611-617.
75. Wolf RL, Alsop DC, Levy-Reis I, et al. Detection of mesial temporal lobe hypoperfusion in patients with temporal lobe epilepsy by use of arterial spin labeled perfusion MR imaging. AJNR Am J Neuroradiol, 2001;22:1334-1341.
76. Doerfler A, Eckstein HH, Eichbaum M, et al. Perfusion-weighted magnetic resonance imaging in patients with carotid artery disease before and after carotid endarterectomy. J Vasc Surg, 2001;34: 587-593.
77. Caramia F, Santoro A, Pantano P, et al. Cerebral hemodynamics on MR perfusion images before and after bypass surgery in patients with giant intracranial aneurysms. AJNR Am J Neuroradiol, 2001;22:1704-1710.
78. Griffiths PD, Wilkinson ID, Mitchell P, et al. Multimodality MR imaging depiction of hemodynamic changes and cerebral ischemia in subarachnoid hemorrhage. AJNR Am J Neuroradiol, 2001;22: 1690-1697.
79. Rordorf G, Koroshetz WJ, Copen WA, et al. Diffusion- and perfusion-weighted imaging in vasospasm after subarachnoid hemorrhage. Stroke, 1999;30:599-605.
80. Cutter FM, Sorensen AG, Weisskoff RM, et al. Perfusion-weighted imaging defects during spontaneous migrainous aura. Ann Neurol, 1998;43:25-31.
81. Cutrer FM, O'Donnell A, Sanchez del Rio. Functional neuroimaging: enhanced understanding of migraine pathophysiology. Neurology, 2000;55(Suppl. 2):S45.
82. Calamante F, Ganesan V, Kirkham FJ, et al. MR perfusion imaging in Moyamoya syndrome: potential implications for clinical evaluation of occlusive cerebrovascular disease. Stroke, 2001;32:2810-2816.
83. Tsuchiya K, Inaoka S, Mizutani Y, Hachiya J. Echo-planar perfusion MR of Moyamoya disease. AJNR Am J Neuroradiol, 1998;19:211-216.
84. Yamada I, Himeno Y, Nagaoka T, et al. Moyamoya disease: evaluation with diffusion-weighted and perfusion echo-planar MR imaging. Radiology, 1999;212:340-347.
85. Michel E, Liu H, Remley KB, et al. Perfusion MR neuroimaging in patients undergoing balloon test occlusion of the internal carotid artery. AJNR Am J Neuroradiol, 2001;22:1590-1596.